LifeMD
LFMD
101 hedge funds and large institutions have $89.9M invested in LifeMD in 2024 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 36 increasing their positions, 30 reducing their positions, and 22 closing their positions.
96% more call options, than puts
Call options by funds: $828K | Put options by funds: $423K
20% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 30
0.62% more ownership
Funds ownership: 39.2% → 39.82% (+0.62%)
4% less funds holding
Funds holding: 105 → 101 (-4)
18% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 22
19% less capital invested
Capital invested by funds: $112M → $89.9M (-$21.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
+$3.96M |
| 2 |
Millennium Management
New York
|
+$3.83M |
| 3 |
QOP
Quinn Opportunity Partners
Charlottesville,
Virginia
|
+$1.55M |
| 4 |
Goldman Sachs
New York
|
+$1.54M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$1.39M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIPM
G2 Investment Partners Management
New York
|
-$2.09M |
| 2 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$2M |
| 3 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
-$1.9M |
| 4 |
Morgan Stanley
New York
|
-$1.66M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$1.3M |
LFMD Hedge Fund Activity: Q3 2024 in Review
101 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in LifeMD (LFMD) for Q3 2024, worth a combined $89.9M — down 19% from $112M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of LFMD and 18 opened new positions — a net loss of 4 holders — while 30 trimmed existing stakes and 36 added.
The largest buyer was AQR Capital Management, opening a new position worth an estimated $3.96M. The largest seller was G2 Investment Partners Management, exiting entirely with an estimated $2.09M sold.
- 101 institutional investors held LifeMD (LFMD) as of Q3 2024, down from 105 in Q2 2024.
- Funds reported $89.9M of LifeMD stock for Q3 2024, down 19% quarter-over-quarter.
- 18 funds opened new LifeMD positions in Q3 2024 and 22 closed out, a net change of -4 holders.
- The largest LifeMD buyer in Q3 2024 was AQR Capital Management, an estimated $3.96M added.
- The largest LifeMD seller in Q3 2024 was G2 Investment Partners Management, an estimated $2.09M sold.
Based on aggregated 13F filings for Q3 2024.